Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study Of Weekly Gemcitabine And Vinorelbine In Children With Recurrent Or Refractory Hodgkin's Disease

NCT00070304 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00070304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00070304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study Of Weekly Gemcitabine And Vinorelbine In Children With Recurrent Or Refractory Hodgkin's Disease
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2004
Completion date
Not reported
Enrollment
33 (actual)
Sites
123

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma